Global Intrauterine Contraceptive Devices Market Size study, by Type (Hormonal Intra uterine device, Copper Intra uterine device), by Product (MIRENA, SKYLA, PARAGARD, ESSURE, LEVOSERT) and by Regional Forecasts 2018-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Intrauterine Contraceptive Devices Market valued approximately USD 1370 million in 2016 is anticipated to grow with a healthy growth rate of more than 10.60% over the forecast period 2017-2025 Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.

Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.

Global Intrauterine Contraceptive Devices MarketThe objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Hormonal Intra uterine device
  • Copper Intra uterine device

By Product:

  • MIRENA
  • SKYLA
  • PARAGARD
  • ESSURE
  • LEVOSERT

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016

Base year – 2017

Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Teva Pharmaceuticals, Ltd, Bayer Healthcare, Pfizer, Merck & co., Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Church & Dwight, Co. Inc., Fuji Latex Co, Ltd, Johnson &Johnson, Ltd.

 and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Intrauterine Contraceptive Devices Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.           Global Intrauterine Contraceptive Devices Market Definition and Scope

1.1.         Research Objective

1.2.         Market Definition

1.3.         Scope of The Study

1.4.         Years Considered for The Study

1.5.         Currency Conversion Rates

1.6.         Report Limitation

Chapter 2.           Research Methodology

2.1.         Research Process

2.1.1.     Data Mining

2.1.2.     Analysis

2.1.3.     Market Estimation

2.1.4.     Validation

2.1.5.     Publishing

2.2.         Research Assumption

Chapter 3.           Executive Summary

3.1.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2.         Key Trends

Chapter 4.           Global Intrauterine Contraceptive Devices Market Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global Intrauterine Contraceptive Devices Market, By Type

5.1.         Market Snapshot

5.2.         Market Performance – Potential Model

5.3.         Global Intrauterine Contraceptive Devices Market, Sub Segment Analysis

5.3.1.     Hormonal Intra uterine device

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.     Copper Intra uterine device

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6.           Global Intrauterine Contraceptive Devices Market, By Product

6.1.         Market Snapshot

6.2.         Market Performance – Potential Model

6.3.         Global Intrauterine Contraceptive Devices Market, Sub Segment Analysis

6.3.1.     MIRENA

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.     SKYLA

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.     PARAGARD

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.     ESSURE

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.     LEVOSERT

6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7.           Global Intrauterine Contraceptive Devices Market, by Regional Analysis

7.1.         Intrauterine Contraceptive Devices Market, Regional Market Snapshot (2015-2025)

7.2.         North America Intrauterine Contraceptive Devices Market Snapshot

7.2.1.     U.S.

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.2. Deployment breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.3. Organization Size breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.4. Industry breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.     Canada

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.2. Deployment breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.3. Organization Size breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.4. Industry breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.         Europe Intrauterine Contraceptive Devices Market Snapshot

7.3.1.     U.K.

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.     Germany

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.     France

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.     Rest of Europe

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.         Asia Intrauterine Contraceptive Devices Market Snapshot

7.4.1.     China

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.     India

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.     Japan

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.     Rest of Asia Pacific

7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.         Latin America Intrauterine Contraceptive Devices Market Snapshot

7.5.1.     Brazil

7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.     Mexico

7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.         Rest of The World

7.6.1.     South America

7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.2.     Middle East and Africa

7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8.           Competitive Intelligence

8.1.         Company Market Share (Subject to Data Availability)

8.2.         Top Market Strategies

8.3.         Company Profiles

8.3.1.     Teva Pharmaceuticals, Ltd

8.3.1.1. Overview

8.3.1.2. Financial (Subject to Data Availability)

8.3.1.3. Product Summary

8.3.1.4. Recent Developments

8.3.2.     Bayer Healthcare

8.3.3.     Pfizer

8.3.4.     Merck & co.

8.3.5.     Agile Therapeutics

8.3.6.     Actavis PLC

8.3.7.     ANI Pharmaceuticals, Inc

8.3.8.     Church & Dwight,Co.Inc.

8.3.9.     Fuji Latex Co, Ltd

8.3.10.   Johnson &Johnson, Ltd.

The research for Global Intrauterine Contraceptive Devices Market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand for Intrauterine Contraceptive Devices across various applications.

The revenue for Global Intrauterine Contraceptive Devices Market is calculated as sum market sizes of different segments such as Type, Product and regions. Further, some other key data points considered to calculate the revenue for Global Intrauterine Contraceptive Devices Market includes:

  • Revenues from key companies
  • Key company market share analysis
  • Consumer spending analysis
  • Regional export and import analysis
  • Sales revenue generated by various applications in different geographies

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts.  


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…